Vulvitis: Clinical Trials

15 trials for Vulvitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed. 15 Phase 2, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 215Completed 15
Phase 12Completed 2
Phase 32Completed 2

Follow Vulvitis: new trials by email Literature Review of Vulvitis trials Research Report on Vulvitis

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Postbiotic as Adjunct Treatment for Vaginal Candidiasis
Postbiotic, Placebo - Vaginal Candidiasis
Phase 2 / Phase 3CompletedMin-Tze LIONG992024-06-022026-07-07
Dose-Finding Study of Oral Ibrexafungep (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis
Fluconazole, SCY-078 - Candida Vulvovaginitis
Phase 2CompletedScynexis, Inc.1862017-08-012021-08-12
ProF-001_Phase IIa
Candiplus, Clotrimazole - Vulvovaginal Candidiasis (VVC)
Phase 2 / Phase 3CompletedProFem GmbH842017-04-042019-03-14
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
Oral Encochleated Amphotericin B (CAMB), Fluconazole - Vulvovaginitis, Yeast Infection
Phase 2CompletedMatinas BioPharma Nanotechnologies, Inc.1372016-11-012018-11-02
TOL-463 Phase 2 Study for Vaginitis
TOL-463 - Bacterial Vaginosis, Vulvovaginal Candidiasis
Phase 2CompletedToltec Pharmaceuticals, LLC1062016-07-152018-03-09
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
CD101 Vaginal Gel (3%), CD101 External gel (1%), CD101 Vaginal Ointment (6%) - Candidiasis, Vulvovaginal, Mycoses
Phase 2CompletedCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1262016-06-082020-08-31
Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Vulvovaginal Candidiasis
SCY-078, Fluconazole - Vulvovaginal Candidiasis
Phase 2CompletedScynexis, Inc.962015-11-012019-07-12
A Study to Evaluate Oral VT-1161 in the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)
VT-1161, Placebo - Recurrent Vulvovaginal Candidiasis
Phase 2CompletedViamet2542015-02-102019-10-15
Probiotic Implementation as Help in Solving Vaginal Infections
Lactobacillus rhamnosus BMX 54 - Vaginal Infection, ASC-US
Phase 2CompletedUniversity of Roma La Sapienza1172015-02-012017-12-13
A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Acute Vaginal Candidiasis (Yeast Infection)
VT-1161, Fluconazole - Candidiasis, Vulvovaginal
Phase 2CompletedViamet552013-08-012018-08-01
Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candidiasis
NDV-3A, NDV-3, Placebo - Vulvovaginal Candidiasis
Phase 1 / Phase 2CompletedNovaDigm Therapeutics, Inc.1882013-07-012018-07-18
MGCD290 and Fluconazole Versus Fluconazole Alone for the Treatment of Moderate to Severe Vulvovaginal Candidiasis
MGCD290 - Vulvovaginal Candidiasis
Phase 2CompletedMethylGene Inc.2202011-12-012013-04-04
Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women
Neo-Penotran® Forte (active ingredient Metronidazole & Miconazole Nitrate), Placebo - Bacterial Vaginosis, Candidiasis
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)2342011-04-012014-10-06
Arasertaconazole Nitrate Pessaries - Dose Finding Study for the Vulvovaginal Candidiasis (VVC) Treatment
arasertaconazole nitrate, placebo - Vulvovaginal Candidiasis
Phase 2CompletedFerrer Internacional S.A.2292010-06-012013-10-09
Phase I/II Randomized, Placebo-Controlled Study of Capsaicin for Interstitial Cystitis and Vulvar Vestibulitis
capsaicin, Placebo - Interstitial Cystitis, Vulvar Diseases
Phase 1 / Phase 2CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1391995-06-012025-05-04

Narrower conditions

Candidiasis, Vulvovaginal (14)  ·  Candidiasis (3)  ·  Vaginitis (2)  ·  Vaginosis, Bacterial (2)  ·  Atypical Squamous Cells of the Cervix (1)  ·  Cystitis, Interstitial (1)  ·  Mycoses (1)  ·  Papillomavirus Infections (1)  ·  Rare Diseases (1)  ·  Torulopsis (1)  ·  Trichomonas Infections (1)  ·  Urogenital Diseases (1)  ·  Vaginal Diseases (1)  ·  Vulvar Diseases (1)  ·  Vulvar Vestibulitis (1)

Broader conditions

Female Urogenital Diseases (15)  ·  Female Urogenital Diseases and Pregnancy Complications (15)  ·  Genital Diseases (15)  ·  Genital Diseases, Female (15)  ·  Bacterial Infections and Mycoses (14)  ·  Infections (14)  ·  Urogenital Diseases (14)  ·  Vulvar Diseases (14)  ·  Mycoses (13)  ·  Vaginal Diseases (13)  ·  Vulvovaginitis (13)  ·  Vaginitis (12)  ·  Candidiasis (11)  ·  Bacterial Infections (2)

Interventions

Fluconazole (5)  ·  VT-1161 (2)  ·  ibrexafungerp (2)  ·  Capsaicin (1)  ·  Clotrimazole (1)  ·  Miconazole (1)  ·  TOL-463 (1)

Sponsors

Scynexis, Inc. (2)  ·  Viamet (2)  ·  Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (1)  ·  Ferrer Internacional S.A. (1)  ·  Matinas BioPharma Nanotechnologies, Inc. (1)  ·  MethylGene Inc. (1)  ·  Min-Tze LIONG (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  NovaDigm Therapeutics, Inc. (1)  ·  ProFem GmbH (1)  ·  Toltec Pharmaceuticals, LLC (1)  ·  University of Roma La Sapienza (1)

Countries

United States (10)  ·  Austria (1)  ·  Dominican Republic (1)  ·  India (1)  ·  Kenya (1)  ·  Malaysia (1)  ·  Spain (1)

Top investigators

David Angulo, MD (2)  ·  Alena Jandourek, MD (1)  ·  Douglas Kling (1)  ·  Gregory Reid, MSc, MBA (1)  ·  Herbert Kiss, Ao.Univ.Prof.Dr. (1)  ·  Hugh Flood (1)  ·  John P. Hennessey, Jr., Ph.D. (1)  ·  Sumita Bhatia, MD (1)

Results publications

PMID 36396498, PMID 29304768, PMID 29534874, PMID 29697768, PMID 30184181, PMID 32818963, PMID 34555149, PMID 40970688

NIH funding

2009 (1), R01DK049524 (1)